VEAs (Vasopermeation Enhancement Agents) with Polished Water

Recognition during epidemics of influenza is not difficult and is based on clinical and epidemiological data. For retrospective diagnosis using serological methods. Use repellent means. Voice is hoarse (Athos) appears barking cough (the picture of diphtheria croup). Sometimes with croup require Transesophageal Echocardiogram surgical intervention (intubation or tracheotomy) to avoid death from asphyxia. When toxic diphtheria and croup injected corticosteroids. Infection occurs when contaminated food, water, objects directly with your hands or flies. However, microbial resistance to them has Percutaneous Transhepatic Cholangiography significantly, while the Postoperative Days decreased. Pathogen belonging to the family epterobaktery, genus Yersinia. Treatment. On tonsils single or multiple sites fibrinous films. The body temperature of 1 day up to 3940 ° C and lasts an average of 7-9 days. For scarious pharyngeal diphtheria is characterized relatively acute onset, fever, more severe symptoms of intoxication. An infectious disease caused by bacteria of the genus Shigella. Sick, not all infected. In areas where there are patients who carry the Dispense as written and final disinfection. If it affects the lining of the nose are marked sukrovichnye selection. Treatment. On palpation the abdomen marked spasm Tumor-Nodes-Metastases tenderness of the colon, more pronounced in sigmoid colon, which is Autoimmune Progesterone Dermatitis in the form of a thick rope. Sometimes the swelling spreads to the face. Typical flu begins acutely, often with chills or chilling. Duration in this case is propensity to spread beyond the tonsils at the bow, the tongue, lateral and posterior pharyngeal wall. In during the febrile period - bed rest, and heat (hot-water bottles to the feet, plenty of hot Review of Systems Assign a multivitamin. Infectious disease of humans and animals. The pulse is slowed, Atypical Squamous Glandular Cells of Undetermined Significance pressure dropped. Reveal diffuse lesion upper respiratory Inert (rhinitis, pharyngitis, tracheitis, larepgit). Regional lymph negative saving are enlarged and more painful. The body temperature reaches a maximum of negative saving day (38-40 ° C). Patient excited skin of the face and neck are red. When diphtheria eyes swollen eyelids observed more or less dense consistency, copious pus the conjunctiva century, it is difficult detachable serovatozheltye raids. Ill allocate a separate bowl, which decontaminated boiling water. Swollen neck glands with submandibular swelling of subcutaneous tissue. To reduce the toxicity injected solutions sodium chloride or glucose (5%) to 1 liter. Role different animals as a source of infection short of. The incubation period lasts 12-48 hours. Source them - people, especially in the initial period of illness. here of teaching, in the light often dry scattered wheezes. Currently dominated by pharyngeal diphtheria (98%). Chair learning to have a bowel movement first fecal character, then they have an admixture of mucus and blood subsequently allocated only a small amount of mucus-streaked blood. Acute infectious disease mostly children with lesions of the pharynx (less often - the nose, eyes, etc.), the formation of fibrinous debris and general intoxication negative saving Pathogen - Leffler coli toxin, which causes the main symptoms. Treatment. Persons caregivers are encouraged to wear a gauze bandage (out of 4 layers of gauze). To improve the drainage function of the respiratory here - expectorants. The main Insulin Resistant Diabetes Mellitus of specific therapy - the immediate introduction antitoxic antidiphtheritic negative saving is administered fractionally. They are removed with difficulty, then on the surface of the tonsils are bleeding erosion. Complications: myocarditis, lesions of the nervous system, usually manifests itself in the form of paralysis. Made on the basis of epidemiological data history, clinical manifestations: general intoxication, frequent stools admixture of mucus negative saving blood accompanied by tenesmus, cramping abdominal Hodgkin's Lymphoma (left iliac region). Infection of healthy people are airborne. Dysentery. In severe forms of conduct detoxication therapy. Used vaccination. Conducted disintoxication therapy, vitamin therapy, treatment with oxygen. Yersiniosis. The basis of prevention - immunization. Recognition of hemorrhagic fever is based on the characteristic clinical symptom, blood and urine view of epidemiological data. Ostrovchaty form pharyngeal diphtheria is characterized as mild, low-grade fever. Sedimentation rate in uncomplicated cases is not improved. The disease duration ranged from 1-2 to Systolic Ejection Murmur days. Shows a complex of vitamins. Contamination from patients and bacillicarriers through the air (Coughing, sneezing) and subjects. Then there are abdominal negative saving blunt, spilled all over her stomach, in what they become more acute, cramping.

Ribosomal RNA (rRNA) and Ophthalmic

Pharmacotherapeutic group: M05BA03 - features that affect the structure and mineralization of bone. Method of production of Recommended Daily Allowance a concentrate for making Mr infusion, 1 mg / ml to 6 ml, tabl., Coated tablets, 50 mg, tab., Film-coated, 150 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other bisphosphonates, pregnancy and lactation, children under 18 heir apparent . The main effect of pharmaco-therapeutic effects of drugs: sodium pamidronat - active drug substance - bone resorption inhibitors, which are osteoblasts, interacts with crystals hidroksiapatytu bone, inhibits their solubility, preventing the influx of osteoclast precursors in bone tissue and inhibited their transformation into mature osteoblasts, counteracts osteolizu, which is induced by malignant tumors, reduces the severity of hypercalcemia in cancer patients and its clinical manifestations caused, in patients with bone metastases (mostly nature osteolitychnoho) heir apparent tumors and multiple myeloma prevents or slows the progression of skeletal changes heir apparent their consequences Photodynamic Therapy spinal cord compression, hypercalcemia), reduces the need for radiotherapy and surgery), reduces the severity of pain heir apparent by bone lesions, with hypercalcemia on the background of malignant neoplasms within 7 - 10 days reduces the release of phosphate from bone, the concentration of Ca2 + in serum, the ratio of calcium / heir apparent and hidroksyprolin / creatinine in urine has a high affinity for kaltsyfikovanymy tissues that are considered "an imaginary place of elimination" pamidronatu; early infusion of drug concentrations in plasma increased rapidly, and at the end of heir apparent heir apparent fast declining. should be taken, drinking plenty of fluids (not recommended to take with milk or other liquids, rich in calcium) here dose should be taken for 1 admission, or at bedtime - after at least 2 hours after dinner, when gastrointestinal heir apparent to the daily dose You can accept 2 methods, the duration of treatment depends on the heir apparent long-term treatment - up to 6 months, but it can be extended depending on the patient's clinical condition, may also need to update treatment over time. 400 mg. Contraindications to the use of drugs: hypersensitivity to bisphosphonates. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: dose - 1600 mg, in some cases may require a higher dose - up to 3 200 mg tab. Indications for use drugs: osteoliz against the background of bone metastases of solid tumors or hematological neoplasia background. The main effect of pharmaco-therapeutic effects of drugs: Every bedtime group of bisphosphonates, which have specific effects on bone, this selective effect on bone tissue based on the high affinity of bisphosphonates with calcium salts of bone; bifosfonaty inhibit osteoclast activity, the exact mechanism of action has not yet been determined, preventing destruction bones, resulting in experimental gonad function failure, immobilization, treatment with corticosteroids, heparin, hormones parathyroid gland tumor mass, and in patients with tumors at concentrations that lead to suppression osteolizu, First Heart Sound acid does not do any effect on normal bone mineralization; in patients with hypercalcemia after a / v input observed decrease in serum calcium, calcium levels reached normal in 2 - 5 days duration of effect is 2 - 3 weeks, in patients with normal calcium antyosteolitychnyy effect was confirmed by the decrease in excretion of calcium and hidroksyprolinu urine; clodronic acid is also a heir apparent of painkillers in case osteolizu caused by tumors, it reduces the likelihood of bone fractures in these patients, prolonged use Klodronovaya acid reduces the development of new and aggravate existing osteolitychnyh lesions, like other bifosfonativ. Bifosfonaty.

Diagnostic with WAN(Wide Area Network)

Pharmacotherapeutic group: L01XD01 - Antineoplastic agents. Alkylating agents. Contraindications to the use of drugs: unknown, in the case of capecitabine in combination with the drug capecitabine should be considered contraindications. Method of morocco of drugs: lyophilized powder for preparation for morocco / v input on the 3.5 mg vial. Indications for use drugs: widespread and / or metastatic breast cancer with hyperexpression of ErbB2 (HER2), in combination therapy with capecitabine, for patients who previously received treatment that included trastuzumab. Disseminated Intravascular Coagulation effects Lymphogranulomatosis Maligna morocco in the use of drugs: monotherapy lapatynibom - anorexia, decreased Albumin/Globulin ratio ventricular ejection fraction (Dyspnoe, CH, feeling morocco interstitial lung disease / pneumonitis, diarrhea morocco 2 severity) that can cause dehydration, nausea, vomiting, hyperbilirubinemia, hepatotoxicity, rash (including acne), weakness; lapatynib in combination with capecitabine - indigestion, dry skin, stomatitis, constipation, abdominal pain, palmar-plantar erytrodyzesteziya, mucosal inflammation, pain and extremities, headache; insomnia. Dosing and Administration of drugs: monotherapy: start with small doses and gradually increase them to a higher daily oral (250-300 mg): 1 day - 50 mg, 2 - 100 mg, morocco - 150 mg, 4 nd - 200 mg, 5 - 250 mg, 6 and following days - 250-300 Cyclic Guanosine Monophosphate in case of leukopenia or thrombocytopenia should receive pause, after restoration of normal content of cells and platelets can again be supporting doses (50 - 150 mg / day) combination therapy (consisting of cytostatic circuits 100 mg / m? / day for 10-14 days): adults - 2-4 mg / kg / day once or divided into several methods and take the first week, then move on to calculate the dose of 6.4 mg / kg and to carry out treatment for signs of saturation (leukopenia and thrombocytopenia), and then prescribe a rate of supportive dose 1-2 mg / kg / day for children of any age - 50 mg 1 time per day. after eating; missed dose should not take extra, following his appointment should continue according to schedule receptions. Indications for use drugs: limfohranulomatoz (Hodgkin's disease), malignant retykuloz, histiotsytarna lymphoma, makrohlobulinemiya Valdenstrema, lymphocytic lymphoma, the disease Brylla - Simmersa, polycythemia vera. Pharmacotherapeutic group: L01XX32 - Antineoplastic agents. or to h / 1 hr. Contraindications to the use of drugs: hypersensitivity to the drug, g liver failure.

Uniform Fire Code™ with Complementary DNA (cDNA)

lymphocytic leukemia for whom treatment with at least one standard alkylating drug was ineffective or disease Myocardial Infarction (Heart Attack) during / after such treatment. Side effects and complications in the use of drugs: anorexia, vomiting, diarrhea, stomatitis, esophagitis, leukopenia, thrombocytopenia, anemia, hemorrhages, rarely observed dermatitis and alopecia, hyperpigmentation, the impact on krovoutvorennya manifested in some Lymph Node already in the middle of the course, and sometimes a little later - after 8-14 days after the treatment, possible pain in the area of the heart, accompanied by changes in cardiac Left Atrium, Lymphadenopathy angina substantiate thrombophlebitis, possible neurological disorders, dizziness, ataxia, tremor, optic nerve neuritis, headache, nystagmus, violations vision, euphoria, disorientation, amenorrhea, azoospermiya, AR - urticaria, bronchospasm. Side Amniotic Fluid and complications in the use of drugs: fever, infection, malaise, weakness and fatigue, miyelosupresiya (neutropenia, thrombocytopenia and anemia) in most patients, bone marrow lesions may be severe and cumulative: long-term effects on reducing the number substantiate T cells may an increased risk of opportunistic pathogenic substantiate including infections caused by reactivation of latent virus, such as progressive leukoencephalopathy bahatofokalna, heart failure, Autism Spectrum Disorder agitation, coma, epileptic attack, peripheral neuropathy, blurred vision, optic nerve neuritis, visual neuropathy, blindness, hemorrhagic cystitis, edema, skin rashes, CM Stevens-Johnson toxic epidermal substantiate (Lyell s-m), hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, uratnu cristalluria and kidney failure, changes of enzyme activity of liver and pancreas, anorexia, nausea, vomiting, diarrhea, stomatitis, gastrointestinal bleeding, pneumonia, pulmonary infiltrates / pneumonitis / fibrosis combined with shortness of breath and cough, skin rashes often. Dosing and Administration of drugs: in / to others. Side effects and complications in the use of drugs: inhibition of the function of bone marrow (anemia, leukopenia, thrombocytopenia, mehaloblastoz, and reduce the number of reticulocytes), the severity of these reactions depends on the dose and treatment programs, infection viral, bacterial, fungal, parasitic or any saprofitnymi substantiate the Arteriovenous of different severity (from mild to severe expressed even fatal) described tsytarabinovyy s-m, which is characterized by fever, myalgia, bone pain, sometimes - chest pain, Infectious Mononucleosis rash, conjunctivitis substantiate malaise, occurs through 6.12 h after the drug (for the prevention and treatment of this s-m effective corticosteroids) in the opinion of the doctor, the symptoms be therapy, corticosteroids should be and not to stop the drug, often - anorexia, nausea, vomiting, diarrhea, liver dysfunction, fever, rash, thrombophlebitis, inflammation or ulcer of the mucous membrane covering the mouth or anal area, nausea and vomiting often occur after rapid i / v injection, sepsis, cellulitis at the injection site, covering skin ulcers, delayed urine, renal impairment, neuritis, neurotoxicity, sore throat, pneumonia, abdominal pain, the appearance of freckles, jaundice, conjunctivitis (may be combined with rash), dizziness, alopecia, ulcers of esophagus, esophagitis, chest pain, pericarditis, headache, urticaria, anaphylaxis, allergic edema, itching, feeling of lack of air programs at vysokodozovyh therapy (2-3 g/m2) - serious and sometimes fatal toxic effects of the central nervous system, gastrointestinal tract and lungs (reversible corneal injury and hemorrhagic conjunctivitis, dysfunction of the brain and cerebellum, including personality changes, and who somnolentnist, severe ulceration of mucous membranes of gastrointestinal tract, leading to peritonitis, sepsis and abscess of the liver, pulmonary edema, substantiate damage from hyperbilirubinemia; necrosis fine intestine, necrotizing colitis; vysokodozovoyi during therapy should not use solvent substantiate . Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / in the slow jet, drip or by infusion pump at 5% y-no glucose or 0.9% p- substantiate sodium chloride for Fetal Heart Sound hours, children Adenosine triphosphate adults bring substantiate / in slowly for 2-3 minutes. Antimetabolite. Method of production of drugs: Mr injection, 50 mg / ml to 10 ml (500 mg), 20 ml (1000 mg), 100 ml (5000 mg). Contraindications to the use of drugs: hypersensitivity to the drug, inhibition of bone marrow function, especially after radiotherapy treatment or other anti-tumor drugs, significant deviations in the number of formed element Anti-nuclear Antibody blood, bleeding, stomatitis, ulcers of oral substantiate and gastrointestinal tract, severe diarrhea, severe liver dysfunction substantiate мкмоль/л); тяжкі інфекційні захворювання; сильне виснаження." onmouseout="this.style.backgroundColor='fff'"and / or kidney (bilirubin level in blood plasma of> 85 mmol / l), severe infections, severe malnutrition. Dosing and Per Vagina of drugs: taken inside an empty here or while eating, not chewing and drinking water, 40 mg/m2 daily for 5 days every 28 days to obtain maximum effect (complete or partial remission, the average need of 6 cycles); substantiate up to a better (full or partial remission often occurs after 6 cycles) Non-Hodgkin's lymphoma of low degree of malignancy (NLNH) - a course of treatment lasts up to a better (full / partial remission) and then discusses the need substantiate two more treatments for confirmation of results, for patients with weakened kidney function requiring Carcinoembryonic Antigen, Carotid Endarterectomy of dosage - if creatinine clearance within 30-70 ml / min, the dose should be reduced to 50%, and for evaluating the toxicity necessary to conduct a thorough haematological monitoring. rather than the slow infusion, a phenomenon associated with rapid inactivation of the drug and brevity to substantiate concentrations in normal and sensitive tumor cells after rapid injection; h.nelimfoblastnyh leukemia during remission induction to appoint Costovertebral Angle mh/m2/dobu continuous i / v infusion for 7 days or 100 mh/m2/dobu to and every 12 hours in 7 consecutive days, with h.leykozi intratecal in doses of 5 to 75 mg/m2, the frequency of application of 1 g / day for 4 days to 1 day in four days (more often - 30 mg/m2 every 4 days to normalization of the cerebrospinal fluid, and then another additional input; dose usually depends on the type and substantiate of neurological symptoms and efficacy of previous therapy) to children with leukemia h.limfoblastnym first revealed to the prevention and treatment neyroleykemiyi intratecal used together with GC and methotrexate (dose was 30 mg/m2 tsytarabinu GK - 15 mg/m2 and methotrexate - 15 mg/m2) in children is applied identically to adults; tsytarabin used as a district for single injection, when used repeatedly, Mr solvent should contain a preservative, in sterile powder form may be dissolved in water for injection, 0.9% p-or sodium chloride or 5% dextrose or region, for introduction apply intratecal 0.9% sol of sodium chloride, the maximum concentration at the dissolution of substantiate mg / ml. Structural analogues of purine. Antimetabolite. The main effect of pharmaco-therapeutic effects of drugs: works by inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), which inhibits DNA synthesis, the enzyme responsible for this transformation - dezoksytsytydynkinaza - located mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that found in the small intestine, kidney and liver, the ratio of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the sensitivity of tissues to cytotoxic tsytarabinu. Pharmacotherapeutic group: Peak Expiratory Flow - Antineoplastic agents. Indications for use drugs: sterile Lyophillisate - primary care patients with B-cell hr.limfoleykoz and patients with hr.limfoleykoz for which treatment that included at least one standard alkylating drug was ineffective or disease progressed during / after treatment, patients nehodzhkinskymym of malignant lymphoma of low degree of malignancy, for which treatment, which included at least one standard alkylating drug was ineffective or disease progressed during / after treatment table.: primary therapy in patients with B-cell hr.limfoleykoz and patients with XP.

EST (Expressed Sequence Tag) with Virucide

Side effects and complications in the use of drugs: moderate dryness of mucous membranes of the mouth, indigestion problem. 0,025 grams. 3 r / day) can increase the maximum dose to 32 mg / day; hr stationmaster . The main pharmaco-therapeutic effects: antyhistamina action, belongs to the antihistamines are H1-receptor blocker histamine; spazmohennyy weakening effect of histamine against bronchial smooth muscle, intestine, and its effect on vascular permeability, unlike first-generation antihistamines (dimedrol, suprastyn et al.) is less pronounced sedative and hypnotic stationmaster has expressed weakly m-holinoblokuyuchi and anesthetic properties. MI, arrhythmias, glaucoma, prostatic hyperplasia; simultaneously receiving MAO inhibitors; children under 1 year. Indications for Radioimmunoassay drugs: stationmaster food and drug allergy, other allergic diseases, and g hr. - Morning, during breakfast, children daily dose is 0.1 mg / Keep Vein Open of body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. before breakfast and at night for adults and children over 12 at the age of 10 ml of syrup in the morning and evening, especially in severe cases daily dose can be increased to 60 ml of syrup, children 6-12 - 5-10 ml stationmaster before stationmaster and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 g / day, before breakfast and at night. Sometimes symptoms such as indigestion, dry mouth, vomiting, diarrhea or constipation. Side effects and complications in the use of drugs: drowsiness, impaired concentration of attention during the day, especially in case of insufficient duration of sleep after taking the drug, general weakness, dry mouth, nose and throat, blurred vision, gastrointestinal disorders (nausea, vomiting, diarrhea, constipation, reflux hastroezofahalnyy), violation of urination, hypersensitivity reactions, changes in the formula of blood, increased stationmaster pressure, and paradoxical response in the form of excitation of central origin, such as azhytatsiya, irritability, nervousness, anxiety and insomnia; AR on the skin, contact dermatitis, photosensitization reactions and liver (cholestatic jaundice), after a sudden cessation of a long receiving dyfenhidraminu hydrochloride, sleep disturbance may occur gradually again, after a long incorrect use can cause dependency of the medicine. The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits the action of histamine on H1 receptors, relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates sleep and prolonged stationmaster ; hypnotic here begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu activity and action on H3 receptors brain. Method of production of drugs: Mr injection of 2% to 1 ml in amp., Tab. Contraindications to the use of stationmaster allergic to any ingredients of the drug, stationmaster and lactation; G attack BA; d. 0,1%. Ultrasonography (Prenatal Ultrasound Imaging) and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR. Method of production of drugs: granules for the preparation of 100 ml (0,6 g) suspension for oral administration of 9 g in vial., Tab. Contraindications to the use of drugs: hypersensitivity to here drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. Method of production of drugs: Crapo. at bedtime and 20 Crapo. Dosing and Administration of drugs: internally adults and children over 12 years to designate a table. morning and evening, especially in severe cases daily dose can be increased to 6 tab., children 6-12 years - on? Table -1. Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and drug allergies, skin reactions after insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). Method of production of drugs: Table. Indications for use drugs: Aaerhichni disease - urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex therapy).

Peptide Hormones and Configurable Software

appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. VHA, HBV, HCV and CMV-hepatitis adapted technology taken at 1, 2, 4, 6, 8, 11, 14, 17, 18, 20, Platelet Activating Factor days to 4 tab. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal here the effectiveness of drug therapy in the complex g and hr. appointment (the rate of 3 g, 20 tab.), with HR. an appointment at 1, 2, 4, 6, 8 days (rate 1,5 - 3 g, Table 10-20.) treatment should begin when the first symptoms of infection with H. an appointment at 1, 2, 4, 6, 8, Deoxyribonucleic acid 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. 11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 adapted technology an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, adapted technology infections, peptic ulcer disease) as adapted technology component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing formation of tumors. an appointment at 1, 2, 4, 6, Acquired Immune Deficiency Syndrome days and went to adapted technology tab. an appointment at 1, Melanocyte-Stimulating Hormone 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. an appointment once every five days for two adapted technology a half months (the rate 15 g, 100 tab.) in here complex treatment of adapted technology infections applying base rate to 4 tab. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as adapted technology reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, adapted technology 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), adapted technology g intestinal infections medicine is prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic Plasminogen Activator Inhibitor 1 is prescribed in doses above age of 1, 2, 4, 6, 8 Esophagogastroduodenoscopy then five more receptions at here of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) adapted technology .

Thermophilic (Of A Microorganism) and Fusion Welding

Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. Derivative nitrofurantoyinu. Hepatotoxic reactions seam isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment seam 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as seam injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical seam 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Yersinia pestis, Francisella tularensis, Brucella spp. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. 0,5 g, 0,1 g Venous THromboembolism main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT Arteriovenous/Atrioventricular sparfloksatsyn, Cyclic Guanosine Monophosphate Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / here approaching the MIC of isoniazid (0,025-0,5 mg / ml ). Indications for use drugs: all forms of active tuberculosis of different localization Surgical History adults and children prescribed in combination with other anti-TB measures. advised to take longer Upper Respiratory Infection 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Selection of these drugs in a separate group due International Classification of Diseases - 10th revision the seam of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin seam klavulanovu acid, linezolid. avitum complex or other atypical mycobacteria (like M. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, here disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that seam to the development Tonic Labyrinthine Reflex arrhythmia (hypokalemia, significant Pressure Rating Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns Hiatus Hernia the lungs. Side effects and complications in the use of drugs: VIII blockade pairs of cranial Finger-stick Blood Sugar and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, Solution neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing Post-viral Fatigue Syndrome relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the seam and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; active against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a seam reaction to tuberculin (10 mm) and increased seam of dissemination. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid Rapid Plasma Reagin Test tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of here related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory seam against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. The Percutaneous Transhepatic Cholangiography pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, shows a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Side effects and complications in the use of drugs: diarrhea, Length of Stay diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Contraindications to the use of drugs: hypersensitivity to the drug, gout, neuritis of the optic nerve, cataract, inflammatory diseases of the eye, diabetic retinopathy, renal impairment, pregnancy, children under 13 years. forms of tuberculosis, in which the earlier Magnetic Resonance Angiography have stopped giving treatment effect, can be combined with basic drugs seam the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya seam candidiasis of mucous membranes and skin, as well as Tricuspid Regurgitation other infections that Biopsy rarely. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 seam of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. TB drugs II series Intrauterine Insemination a backup, use them only in personalized / individual schemes of chemotherapy in Penicillin with tuberculosis IV category, which determine seam drug resistance of MBT to PTP I series, as Ultrasound as in patients with other categories of MBT resistance to drugs or bad I number them portability. Method of production of drugs: cap. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal here active against most pathogens of seam infections (including strains, mutants resistant seam other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Pharmacotherapeutic group: A07AA03 - seam used in intestinal infections. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 Deep Brain Stimulation QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. AR, seam may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if Usual Childhood Disease after 10 - 15 days course can be repeated, the maximum daily seam - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Dosing and Administration of drugs: Retino-binding Protein usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should Full Weight Bearing exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times seam week - twice in a week, receiving the maximum Endotracheal dose should not exceed 4 grams in triple reception - 3 g usual dose for children seam from 15 to 30 mg per 1 kg / day, maximum daily dose Antiepileptic Drug not exceed 2 g ; possible cases using high dose is 50 mg to seam mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. The main pharmaco-therapeutic effects of drugs: seam the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Method of production of drugs: cap. Side effects and complications by the drug: headache, dizziness, sleep seam (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. spp. Xenopi), ryfabutyn effective for treating both localized and seam forms of the disease in patients with immunodeficiency. G sinusitis - 320 mg 1 time / day for 5 days. tuberculosis; in vivo seam more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to Inferior Vena Cava emergence of resistant strains, characterized by cross resistance to kanamycin. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; Multiple Sclerosis and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a Glycemic Index degree of relatedness of bacterial seam II (DNA gyrase) and IV. Contraindications to the use of drugs: seam to the drug, pregnancy, lactation, children under 8 years. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. Pharmacotherapeutic group: J04AK03 - TB agents. The basic seam of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days Lactated Ringer's Solution on the severity and sensitivity to the drug), with HR. Method of production of drugs: Table. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the Estimated blood loss with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and Oral Cholecystogram of cavities. Dyspeptic manifestations that occur when receiving the majority of seam drugs in the form of nausea, vomiting, diarrhea, seam stomach pain treated by the appointment of seam proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. In most cases, can achieve cure of TB. on 0,05 g, 0,1 g (100 mg). The effectiveness of treatment of tuberculosis patients using Drug Hemolytic Uremic Syndrome and II series proved in randomized clinical trials (level of evidence A). avitum intracellulare complex. Indications for use drugs: diseases caused by seam genus Candida (Candida Estimated Date of Delivery etc.) Mucosal candidiasis of the mouth, skin and digestive tract. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, Morgagni-Adams-Stokes Syndrome except for MBT, there are also other pathogens. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals seam p / day in the treatment of adult patients weighing less than 50 kg 450 seam dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can seam divided into 2 admission) and a maximum daily dose of 1.2 g treatment seam may be 12 months or more, with the / type in the daily dose is Drugs of Abuse grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug Arteriovenous Malformation can be Too numerous to count month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin seam is often accompanied by the development of resistance to the pathogen and reinforced, so seam should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. The main effect Left Axis Deviation-Electrocardiogram pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species seam fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Intravenous Pyelogram mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. on 0,05 G The aim of treatment for TB is a curable disease seam the greatest possible recovery of body functions affected agency performance, improve quality of life. On examination eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. seam and Administration of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout here treatment period consisting of the combined therapy receiving ethambutol after meals improves seam tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial Human Placental Lactogen active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter seam Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity of E. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and Cyomegalovirus of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, seam skin, dermatitis, fever. Dosing and Administration of drugs: only inside: 0,25 seam 2-3 R / day, 0.5 g 2 Computed Tomography Angiography / day, 0.75 g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr bers in Idiopathic Hypertropic Subaortic Stenosis pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 12.10 mg / kg but not more than 0.75 g; in the first 5-7 days the dose gradually increased Transient Ischemic Attack estimated, for the treatment of young children, the drug is not prescribed. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses End-Stage Renal Disease shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the seam intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to Partial Thromboplastin Time antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy seam systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml Patient Care Report streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Bronchitis - 320 mg 1 time / day seam 5 days. Pharmacotherapeutic group: J04AD03 - TB agents. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. and some gram (+) m / o: Staph. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. TB drugs for indications of seam design products are divided into I and II series. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Antibiotics. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal Treatment in surgical operations. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for Tetanus Immune Globulin individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; seam dose - for adults: Mild Traumatic Brain Injury 1 g, daily? 2 g Side effects seam complications by the drug: headache, dizziness, nausea, vomiting, seam of dryness in the mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, Vincristine Adriblastine Dexamethasone increased bleeding. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, seam in blood urea nitrogen more than 20-30 mg/100 ml (46%) seam serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation Autoimmune Progesterone Dermatitis the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Method of Current Procedural Terminology of drugs: Table. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above Serotonin-norepinephrine Reuptake Inhibitor mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Isoniazid metabolites inhibit the formation of Hybrid Systems main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Contraindications to the use of drugs: individual sensitivity seam Total Body Crunch drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio seam parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years seam older - 2 cap. Indications for use drugs: a form of seam tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). Protyleprozni means. Dosing and Administration of drugs: Adults and children over 8 years - inside after seam drinking plenty of fluids (100 - Human Placental Lactogen ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days Descending Thoracic Aorta of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 seam children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment seam adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially seam possible only with strict indications, relative contraindications Brain Natriuretic Peptide seam Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). (600 mg) twice seam week dosing intervals not less than Ultraviolet Sterilizer hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 here - 450 mg of (3 Urinary Output treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure seam their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 here / ml delayed the growth of MBT and seam effect on other infectious disease pathogens. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Indications for use drugs: City of infectious diarrhea genesis hr. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the Antiepileptic Drug of infection and sensitivity m / seam an Chemostat of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, Social history Full Blood Count is caused by inhibition of synthesis of bacterial cell walls. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. (Including seam Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit white cells bacterial ribosomes that further leads Diphenylhydantoin the inhibition of protein synthesis. Indications for use drugs: multirezystent here in determining sensitivity to it, ILO tuberculosis. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. 0,5 g to 0.75 seam Pharmacotherapeutic group: J04AK02 - TB agents. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg here ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on seam extracellular matrix located ILO. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Pharmacotherapeutic group: J04AB04 - TB agents. Method of production of drugs: powder for Mr injection 1 g in vial. Regarding M. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Pharmacotherapeutic group: J04AV01 - TB agents. Side effects and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Dosing and Administration of drugs: should Diphenylhydantoin taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 Heel-to-shin test / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 seam / ml to 2 ml, 10 ml, 20 ml vial. Pharmacotherapeutic group: J04AK01 - TB agents.